Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Virol

Retrieve available abstracts of 54 articles:
HTML format
Text format



Single Articles


    June 2018
  1. HIROSE Y, Onuki M, Tenjimbayashi Y, Mori S, et al
    Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  2. WOAPPI Y, Hosseinipour M, Creek KE, Pirisi L, et al
    Stem Cell Properties of Normal Human Keratinocytes Determine Transformation Responses to Human Papillomavirus 16 DNA.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    May 2018
  3. THATTE J, Massimi P, Thomas M, Boon SS, et al
    The HPV E6 PDZ Binding Motif links DNA Damage Response Signaling to E6 Inhibition of p53 Transcriptional Activity.
    J Virol. 2018 May 30. pii: JVI.00465-18. doi: 10.1128/JVI.00465.
    PubMed     Text format     Abstract available


  4. CHIU YF, Sugden B
    Plasmid Partitioning by Human Tumor Viruses.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    April 2018
  5. GUMPPER RH, Li W, Castaneda CH, Scuderi MJ, et al
    A Polyamide Inhibits Replication of Vesicular Stomatitis Virus by Targeting RNA in the Nucleocapsid.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  6. WOODBY BL, Songock WK, Scott ML, Raikhy G, et al
    Induction of Interferon Kappa in Human Papillomavirus 16 Infection by Transforming Growth Factor Beta-Induced Promoter Demethylation.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  7. WESTRICH JA, Warren CJ, Klausner MJ, Guo K, et al
    Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    March 2018
  8. SIDDIQA A, Massimi P, Pim D, Broniarczyk J, et al
    Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  9. CHIANG C, Pauli EK, Biryukov J, Feister KF, et al
    The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


    February 2018
  10. POUYANFARD S, Spagnoli G, Bulli L, Balz K, et al
    Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  11. VAN DE POEL S, Dreer M, Velic A, Macek B, et al
    Identification and Functional Characterization of Phosphorylation Sites of the Human Papillomavirus 31 E8^E2 Protein.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available


  12. BIRYUKOV J, Meyers C
    Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.
    J Virol. 2018 Feb 7. pii: JVI.01993-17. doi: 10.1128/JVI.01993.
    PubMed     Text format     Abstract available


  13. LOPES PP, Todorov G, Pham TT, Nesburn AB, et al
    Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8(+) TEM and TRM Cell Responses Against Herpes Infection and Disease(double dagger).
    J Virol. 2018 Feb 7. pii: JVI.02156-17. doi: 10.1128/JVI.02156.
    PubMed     Text format     Abstract available


    December 2017
  14. HONG S, Cheng S, Songock W, Bodily J, et al
    Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  15. GHIASI H
    Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?
    J Virol. 2017;91.
    PubMed     Text format    


    November 2017
  16. THOMAS Y, Androphy EJ
    HPV Replication Regulation by Acetylation of a Conserved Lysine in the E2 Protein.
    J Virol. 2017 Nov 15. pii: JVI.01912-17. doi: 10.1128/JVI.01912.
    PubMed     Text format     Abstract available


  17. CHEN Z, Ho WCS, Boon SS, Law PTY, et al
    Ancient Evolution and Dispersion of Human Papillomavirus 58 Variants.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    October 2017
  18. WALLACE NA, Khanal S, Robinson KL, Wendel SO, et al
    High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  19. XIE F, DeSmet M, Kanginakudru S, Jose L, et al
    Kinase Activity of Fibroblast Growth Factor Receptor 3 Regulates Activity of the Papillomavirus E2 Protein.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  20. PACINI L, Ceraolo MG, Venuti A, Melita G, et al
    UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  21. VAN DER WEELE P, Meijer CJLM, King AJ
    Whole-Genome Sequencing and Variant Analysis of Human Papillomavirus 16 Infections.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    September 2017
  22. BAGRI P, Anipindi VC, Nguyen PV, Vitali D, et al
    A novel role for IL-17 in enhancing type 1 helper T cell immunity in the female genital tract following mucosal HSV-2 vaccination.
    J Virol. 2017 Sep 27. pii: JVI.01234-17. doi: 10.1128/JVI.01234.
    PubMed     Text format     Abstract available


  23. MINAYA MA, Jensen T, Goll J, Korom M, et al
    Molecular evolution of herpes simplex virus 2 complete genomes: Comparison between primary and recurrent infections.
    J Virol. 2017 Sep 20. pii: JVI.00942-17. doi: 10.1128/JVI.00942.
    PubMed     Text format     Abstract available


    August 2017
  24. THATTE J, Banks L
    HPV-16, HPV-18 and HPV-31 E6 override the normal phospho-regulation of E6AP enzymatic activity.
    J Virol. 2017 Aug 23. pii: JVI.01390-17. doi: 10.1128/JVI.01390.
    PubMed     Text format     Abstract available


  25. SCHAFER G, Graham LM, Lang DM, Blumenthal MJ, et al
    Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    May 2017
  26. DAS D, Smith N, Wang X, Morgan IM, et al
    The Deacetylase SIRT1 Regulates the Replication Properties of Human Papillomavirus 16 E1 and E2.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  27. DAY PM, Thompson CD, Lowy DR, Schiller JT, et al
    Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    April 2017
  28. SZALMAS A, Tomaic V, Basukala O, Massimi P, et al
    The PTPN14 Tumor Suppressor Is a Degradation Target of Human Papillomavirus E7.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    March 2017
  29. MORI S, Takeuchi T, Ishii Y, Yugawa T, et al
    Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  30. CAMPOS-LEON K, Wijendra K, Siddiqa A, Pentland I, et al
    Association of Human Papillomavirus 16 E2 with Rad50-Interacting Protein 1 Enhances Viral DNA Replication.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    January 2017
  31. CULLETON SP, Kanginakudru S, DeSmet M, Gilson T, et al
    Phosphorylation of the Bovine Papillomavirus E2 Protein on Tyrosine Regulates Its Transcription and Replication Functions.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


  32. HARRIS L, McFarlane-Majeed L, Campos-Leon K, Roberts S, et al
    The Cellular DNA Helicase ChlR1 Regulates Chromatin and Nuclear Matrix Attachment of the Human Papillomavirus 16 E2 Protein and High-Copy-Number Viral Genome Establishment.
    J Virol. 2016;91.
    PubMed     Text format     Abstract available


    October 2016
  33. BRZEZINSKI JD, Felkner R, Modi A, Liu M, et al
    Phosphorylation requirement of murine leukemia virus p12.
    J Virol. 2016 Oct 5. pii: JVI.01178.
    PubMed     Text format     Abstract available


    June 2016
  34. STRICKLAND SW, Vande Pol S
    The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
    J Virol. 2016;90:5611-21.
    PubMed     Text format     Abstract available


  35. JELEN MM, Chen Z, Kocjan BJ, Hosnjak L, et al
    Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.
    J Virol. 2016;90:5503-13.
    PubMed     Text format     Abstract available


    May 2016
  36. KLYMENKO T, Hernandez-Lopez H, MacDonald AI, Bodily JM, et al
    Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
    J Virol. 2016;90:5047-58.
    PubMed     Text format     Abstract available


    March 2016
  37. CHAPPELL WH, Gautam D, Ok ST, Johnson BA, et al
    Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.
    J Virol. 2015;90:2639-52.
    PubMed     Text format     Abstract available


  38. BERGVALL M, Gagnon D, Titolo S, Lehoux M, et al
    Requirement for the E1 Helicase C-Terminal Domain in Papillomavirus DNA Replication In Vivo.
    J Virol. 2016;90:3198-211.
    PubMed     Text format     Abstract available


    January 2016
  39. HABIGER C, Jager G, Walter M, Iftner T, et al
    Interferon Kappa Inhibits Human Papillomavirus 31 Transcription by Inducing Sp100 Proteins.
    J Virol. 2015;90:694-704.
    PubMed     Text format     Abstract available


    December 2015
  40. GODI A, Facchetti A, Bissett SL, Cocuzza C, et al
    Naturally-Occurring Major and Minor Capsid Protein Variants of HPV45: Differential Recognition by Cross-Neutralizing Antibodies Generated by the HPV Vaccines.
    J Virol. 2015 Dec 30. pii: JVI.02859.
    PubMed     Text format     Abstract available


    November 2015
  41. PACINI L, Savini C, Ghittoni R, Saidj D, et al
    Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
    J Virol. 2015;89:11396-405.
    PubMed     Text format     Abstract available


    October 2015
  42. DIGIUSEPPE S, Keiffer TR, Bienkowska-Haba M, Luszczek W, et al
    Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
    J Virol. 2015;89:10442-52.
    PubMed     Text format     Abstract available


    September 2015
  43. BURREL S, Desire N, Marlet J, Dacheux L, et al
    Genetic diversity within alphaherpesviruses: characterization of a novel variant of herpes simplex virus type 2 (HSV-2).
    J Virol. 2015 Sep 23. pii: JVI.01959.
    PubMed     Text format     Abstract available


  44. VANDEUSEN HR, Kalejta RF
    Deficiencies in cellular processes modulated by the retinoblastoma protein do not account for reduced human cytomegalovirus replication in its absence.
    J Virol. 2015 Sep 16. pii: JVI.01718.
    PubMed     Text format     Abstract available


    August 2015
  45. CHEN AA, Gheit T, Franceschi S, Tommasino M, et al
    Human Papillomavirus Type 18 Genetic Variation and Cervical Cancer Risk Worldwide.
    J Virol. 2015 Aug 12. pii: JVI.01747.
    PubMed     Text format     Abstract available


  46. LO CIGNO I, De Andrea M, Borgogna C, Albertini S, et al
    The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.
    J Virol. 2015;89:7506-20.
    PubMed     Text format     Abstract available


  47. BISSETT SL, Godi A, Fleury MJ, Touze A, et al
    Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype.
    J Virol. 2015;89:7748-57.
    PubMed     Text format     Abstract available


    July 2015
  48. PIM D, Broniarczyk J, Bergant M, Playford MP, et al
    A NOVEL PDZ DOMAIN INTERACTION MEDIATES THE BINDING BETWEEN HPV-16 L2 AND SORTING NEXIN 27 AND MODULATES VIRION TRAFFICKING.
    J Virol. 2015 Jul 22. pii: JVI.01499.
    PubMed     Text format     Abstract available


  49. BOUKHVALOVA M, McKay J, Mbaye A, Sanford-Crane H, et al
    Efficacy of HSV-2 Glycoprotein D/AS04 vaccine against genital HSV-2 and HSV-1 infection and disease in the cotton rat Sigmodon hispidus model.
    J Virol. 2015 Jul 15. pii: JVI.01387.
    PubMed     Text format     Abstract available


  50. SEAY K, Khajoueinejad N, Zheng JH, Kiser P, et al
    The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model is Facilitated by Coinfection with HSV-2 and is Inhibited by Microbicide Treatment.
    J Virol. 2015 Jul 8. pii: JVI.01326.
    PubMed     Text format     Abstract available


  51. STRAUB E, Fertey J, Dreer M, Iftner T, et al
    Characterization of the Human Papillomavirus 16 E8 Promoter.
    J Virol. 2015;89:7304-13.
    PubMed     Text format     Abstract available


  52. CERQUEIRA C, Samperio Ventayol P, Vogeley C, Schelhaas M, et al
    Kallikrein-8 Proteolytically Processes Human Papillomaviruses in the Extracellular Space To Facilitate Entry into Host Cells.
    J Virol. 2015;89:7038-52.
    PubMed     Text format     Abstract available


    June 2015
  53. AWASTHI S, Mahairas GG, Shaw CE, Huang ML, et al
    A dual modality HSV-2 vaccine for preventing genital herpes using glycoproteins C and D subunit antigens to induce potent antibody responses and adenovirus vectors containing capsid and tegument proteins as T cell immunogens.
    J Virol. 2015 Jun 3. pii: JVI.01089.
    PubMed     Text format     Abstract available


    May 2015
  54. MCFARLANE M, MacDonald AI, Stevenson A, Graham SV, et al
    Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    J Virol. 2015;89:5276-87.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: